Membrane Transport
Total Page:16
File Type:pdf, Size:1020Kb
Load more
Recommended publications
-
A Computational Model of Large Conductance Voltage and Calcium
Journal of Computational Neuroscience (2019) 46:233–256 https://doi.org/10.1007/s10827-019-00713-9 A computational model of large conductance voltage and calcium activated potassium channels: implications for calcium dynamics and electrophysiology in detrusor smooth muscle cells Suranjana Gupta1 · Rohit Manchanda1 Received: 11 September 2018 / Revised: 14 February 2019 / Accepted: 19 February 2019 / Published online: 25 April 2019 © Springer Science+Business Media, LLC, part of Springer Nature 2019 Abstract The large conductance voltage and calcium activated potassium (BK) channels play a crucial role in regulating the excitability of detrusor smooth muscle, which lines the wall of the urinary bladder. These channels have been widely characterized in terms of their molecular structure, pharmacology and electrophysiology. They control the repolarising and hyperpolarising phases of the action potential, thereby regulating the firing frequency and contraction profiles of the smooth muscle. Several groups have reported varied profiles of BK currents and I-V curves under similar experimental conditions. However, no single computational model has been able to reconcile these apparent discrepancies. In view of the channels’ physiological importance, it is imperative to understand their mechanistic underpinnings so that a realistic model can be created. This paper presents a computational model of the BK channel, based on the Hodgkin-Huxley formalism, constructed by utilising three activation processes — membrane potential, calcium inflow from voltage-gated calcium channels on the membrane and calcium released from the ryanodine receptors present on the sarcoplasmic reticulum. In our model, we attribute the discrepant profiles to the underlying cytosolic calcium received by the channel during its activation. The model enables us to make heuristic predictions regarding the nature of the sub-membrane calcium dynamics underlying the BK channel’s activation. -
Cystine–Glutamate Antiporter Xct Deficiency Suppresses Tumor Growth While Preserving Antitumor Immunity
Cystine–glutamate antiporter xCT deficiency suppresses tumor growth while preserving antitumor immunity Michael D. Arensmana, Xiaoran S. Yanga, Danielle M. Leahya, Lourdes Toral-Barzaa, Mary Mileskia, Edward C. Rosfjorda, Fang Wanga, Shibing Dengb, Jeremy S. Myersa, Robert T. Abrahamb, and Christina H. Enga,1 aOncology Research & Development, Pfizer, Pearl River, NY 10965; and bOncology Research & Development, Pfizer, San Diego, CA 92121 Edited by William G. Kaelin Jr., Dana-Farber Cancer Institute and Brigham and Women’s Hospital, Harvard Medical School, Boston, MA, and approved April 2, 2019 (received for review September 1, 2018) T cell-invigorating cancer immunotherapies have near-curative Thus, tumor cells may rely on xCT to fulfill the majority of their potential. However, their clinical benefit is currently limited, as cysteine and GSH needs by importing cystine. only a fraction of patients respond, suggesting that these regimens Inhibition of xCT has been investigated as a therapeutic may benefit from combination with tumor-targeting treatments. As strategy for cancer based on observations that elevated xCT ex- oncogenic progression is accompanied by alterations in metabolic pression on tumor cells correlates with poor prognosis (10–12) pathways, tumors often become heavily reliant on antioxidant and that inhibition of xCT in preclinical studies suppresses tumor machinery and may be susceptible to increases in oxidative stress. growth (10, 12–14). However, these studies relied heavily on the The cystine–glutamate antiporter xCT is frequently overexpressed in use of sulfasalazine, a clinical compound used for the treatment cancer and fuels the production of the antioxidant glutathione; thus, of rheumatoid arthritis, ulcerative colitis, and Crohn’s disease. -
Spring 2013 Lecture 23
CHM333 LECTURES 23: 3/25/13 SPRING 2013 Professor Christine Hrycyna LIPIDS III EFFECT OF CHOLESTEROL ON MEMBRANES: - Bulky rigid molecule - Moderates fluidity of membranes – both increases and decreases o Cholesterol in membranes DECREASES fluidity because it is rigid o Prevents crystallization (making solid) of fatty acyl side chains by fitting between them. Disrupts close packing of fatty acyl chains. Therefore, INCREASED fluidity BIOLOGICAL MEMBRANES CONTAIN PROTEINS AS WELL AS LIPIDS: - Proteins are 20-80% of cell membrane - Rest is lipid or carbohydrate; supramolecular assembly of lipid, protein and carbohydrate - Proteins are also distributed asymmetrically - TWO classes of Membrane Proteins: o Integral Membrane Proteins o Peripheral Membrane Proteins 178 CHM333 LECTURES 23: 3/25/13 SPRING 2013 Professor Christine Hrycyna - INTEGRAL MEMBRANE PROTEINS o Located WITHIN the lipid bilayer o Usually span the bilayer one or more times – called transmembrane (TM) proteins o Hydrophobic amino acids interact with fatty acid chains in the hydrophobic core of the membrane o Can be removed from the membrane with detergents like SDS – need to disrupt the hydrophobic interactions § Membrane Disruption Animation: o http://www.youtube.com/watch?v=AHT37pvcjc0 o Function: § Transporters – moving molecules into or out of cells or cell membranes § Receptors – transmitting signals from outside of the cell to the inside - β Barrel Integral Membrane Proteins § Barrel-shaped membrane protein that is made up of antiparallel β-strands with hydrophilic (interior) and hydrophobic (facing lipid tails). § So far found only in outer membranes of Gram-negative bacteria, cell wall of Gram-positive bacteria, and outer membranes of mitochondria and chloroplasts. 179 CHM333 LECTURES 23: 3/25/13 SPRING 2013 Professor Christine Hrycyna - α-Helical Membrane Proteins - Can cross the membrane once or many times and have multiple transmembrane segments. -
Biological Membranes and Transport Membranes Define the External
Biological Membranes and Transport Membranes define the external boundaries of cells and regulate the molecular traffic across that boundary; in eukaryotic cells, they divide the internal space into discrete compartments to segregate processes and components. Membranes are flexible, self-sealing, and selectively permeable to polar solutes. Their flexibility permits the shape changes that accompany cell growth and movement (such as amoeboid movement). With their ability to break and reseal, two membranes can fuse, as in exocytosis, or a single membrane-enclosed compartment can undergo fission to yield two sealed compartments, as in endocytosis or cell division, without creating gross leaks through cellular surfaces. Because membranes are selectively permeable, they retain certain compounds and ions within cells and within specific cellular compartments, while excluding others. Membranes are not merely passive barriers. Membranes consist of just two layers of molecules and are therefore very thin; they are essentially two-dimensional. Because intermolecular collisions are far more probable in this two-dimensional space than in three-dimensional space, the efficiency of enzyme-catalyzed processes organized within membranes is vastly increased. The Molecular Constituents of Membranes Molecular components of membranes include proteins and polar lipids, which account for almost all the mass of biological membranes, and carbohydrate present as part of glycoproteins and glycolipids. Each type of membrane has characteristic lipids and proteins. The relative proportions of protein and lipid vary with the type of membrane, reflecting the diversity of biological roles (as shown in table 12-1, see below). For example, plasma membranes of bacteria and the membranes of mitochondria and chloroplasts, in which many enzyme-catalyzed processes take place, contain more protein than lipid. -
Osmosis, Diffusion, and Membrane Transport Bio 219 Napa Valley College Dr
Osmosis, Diffusion, and Membrane Transport Bio 219 Napa Valley College Dr. Adam Ross Overview In order to understand how cells regulate themselves, we must first understand how things move into and out of cells Diffusion • Diffusion is the movement of particles from an area of high charge or concentration to an area of lower charge or concentration • Referred to as moving “down” a charge or concentration gradient • Ex. H+ ions in mitochondria moving through ATP synthase • Result of random molecular motion • Fick’s Law of Diffusion gives rate of diffusion: • Rate = P A (Cout – Cin) / (x) • Rate is proportional to permeability (P), surface area (A), concentration gradient (Cout – Cin); inversely proportional to diffusion distance or membrane thickness (x) Gradients • Concentration • Caused by unequal distribution of a substance on either side of the membrane • If the inside of a cell is negative, it will attract positively charged things • Electrical (charge) • Caused by unequal distribution of charge on either side of the membrane Diffusion Osmosis • Osmosis is the movement of solvent through a semi permeable membrane in order to balance the solute concentration on either side of the membrane. • In cells the solvent is water • Water can cross membranes Osmosis Osmolarity • Total concentration of all solutes in a solution • 1 Osm = 1 mole solute/ L • Have to account for both atoms in salts • 1M NaCl +1 L H2O → 1M Na+ + 1M Cl ≈ 2 Osm • Plasma = 290 mOsm Osmotic pressure • This is the actual driving force for net water movement • Depends on -
Pharmacokinetics, Pharmacodynamics and Drug
pharmaceutics Review Pharmacokinetics, Pharmacodynamics and Drug–Drug Interactions of New Anti-Migraine Drugs—Lasmiditan, Gepants, and Calcitonin-Gene-Related Peptide (CGRP) Receptor Monoclonal Antibodies Danuta Szkutnik-Fiedler Department of Clinical Pharmacy and Biopharmacy, Pozna´nUniversity of Medical Sciences, Sw.´ Marii Magdaleny 14 St., 61-861 Pozna´n,Poland; [email protected] Received: 28 October 2020; Accepted: 30 November 2020; Published: 3 December 2020 Abstract: In the last few years, there have been significant advances in migraine management and prevention. Lasmiditan, ubrogepant, rimegepant and monoclonal antibodies (erenumab, fremanezumab, galcanezumab, and eptinezumab) are new drugs that were launched on the US pharmaceutical market; some of them also in Europe. This publication reviews the available worldwide references on the safety of these anti-migraine drugs with a focus on the possible drug–drug (DDI) or drug–food interactions. As is known, bioavailability of a drug and, hence, its pharmacological efficacy depend on its pharmacokinetics and pharmacodynamics, which may be altered by drug interactions. This paper discusses the interactions of gepants and lasmiditan with, i.a., serotonergic drugs, CYP3A4 inhibitors, and inducers or breast cancer resistant protein (BCRP) and P-glycoprotein (P-gp) inhibitors. In the case of monoclonal antibodies, the issue of pharmacodynamic interactions related to the modulation of the immune system functions was addressed. It also focuses on the effect of monoclonal antibodies on expression of class Fc gamma receptors (FcγR). Keywords: migraine; lasmiditan; gepants; monoclonal antibodies; drug–drug interactions 1. Introduction Migraine is a chronic neurological disorder characterized by a repetitive, usually unilateral, pulsating headache with attacks typically lasting from 4 to 72 h. -
Membrane Transport, Absorption and Distribution of Drugs
Chapter 2 1 Pharmacokinetics: Membrane Transport, Absorption and Distribution of Drugs Pharmacokinetics is the quantitative study of drug movement in, through and out of the body. The overall scheme of pharmacokinetic processes is depicted in Fig. 2.1. The intensity of response is related to concentration of the drug at the site of action, which in turn is dependent on its pharmacokinetic properties. Pharmacokinetic considerations, therefore, determine the route(s) of administration, dose, and latency of onset, time of peak action, duration of action and frequency of administration of a drug. Fig. 2.1: Schematic depiction of pharmacokinetic processes All pharmacokinetic processes involve transport of the drug across biological membranes. Biological membrane This is a bilayer (about 100 Å thick) of phospholipid and cholesterol molecules, the polar groups (glyceryl phosphate attached to ethanolamine/choline or hydroxyl group of cholesterol) of these are oriented at the two surfaces and the nonpolar hydrocarbon chains are embedded in the matrix to form a continuous sheet. This imparts high electrical resistance and relative impermeability to the membrane. Extrinsic and intrinsic protein molecules are adsorbed on the lipid bilayer (Fig. 2.2). Glyco- proteins or glycolipids are formed on the surface by attachment to polymeric sugars, 2 aminosugars or sialic acids. The specific lipid and protein composition of different membranes differs according to the cell or the organelle type. The proteins are able to freely float through the membrane: associate and organize or vice versa. Some of the intrinsic ones, which extend through the full thickness of the membrane, surround fine aqueous pores. CHAPTER2 Fig. -
Cellular Transport Notes About Cell Membranes
Cellular Transport Notes @ 2011 Center for Pre-College Programs, New Jersey Institute of Technology, Newark, New Jersey About Cell Membranes • All cells have a cell membrane • Functions: – Controls what enters and exits the cell to maintain an internal balance called homeostasis TEM picture of a – Provides protection and real cell membrane. support for the cell @ 2011 Center for Pre-College Programs, New Jersey Institute of Technology, Newark, New Jersey 1 About Cell Membranes (continued) 1.Structure of cell membrane Lipid Bilayer -2 layers of phospholipids • Phosphate head is polar (water loving) Phospholipid • Fatty acid tails non-polar (water fearing) • Proteins embedded in membrane Lipid Bilayer @ 2011 Center for Pre-College Programs, New Jersey Institute of Technology, Newark, New Jersey Polar heads Fluid Mosaic love water Model of the & dissolve. cell membrane Non-polar tails hide from water. Carbohydrate cell markers Proteins @ 2011 Center for Pre-College Programs, New Jersey Institute of Technology, Newark, New Jersey 2 About Cell Membranes (continued) • 4. Cell membranes have pores (holes) in it • Selectively permeable: Allows some molecules in and keeps other molecules out • The structure helps it be selective! Pores @ 2011 Center for Pre-College Programs, New Jersey Institute of Technology, Newark, New Jersey Structure of the Cell Membrane Outside of cell Carbohydrate Proteins chains Lipid Bilayer Transport Protein Phospholipids Inside of cell (cytoplasm) @ 2011 Center for Pre-College Programs, New Jersey Institute of Technology, Newark, New Jersey 3 Types of Cellular Transport • Passive Transport celldoesn’tuseenergy 1. Diffusion 2. Facilitated Diffusion 3. Osmosis • Active Transport cell does use energy 1. -
Chapter 2 Cell Membranes
Chapter 2 Cell Membranes © 2020 Elsevier Inc. All rights reserved. Figure 2–1 The hydrophobic effect drives rearrangement of lipids, including the formation of bilayers. The driving force of the hydrophobic effect is the tendency of water molecules to maximize their hydrogen bonding between the oxygen and hydrogen atoms. Phospholipids placed in water would potentially disrupt the hydrogen bonding of water clusters. This causes the phospholipids to bury their nonpolar tails by forming micelles, bilayers, or monolayers. Which of the lipid structures is preferred depends on the lipids and the environment. The shape of the molecules (size of the head group and characteristics of the side chains) can determine lipid structure. (A) Molecules that have an overall inverted conical shape, such as detergent molecules, form structures with a positive curvature, such as micelles. (B) Cylindrical-shaped lipid molecules such as some phospholipids preferentially form bilayer structures. (C) Biological membranes combine a large variety of lipid molecular species. The combination of these structures determines the overall shape of the bilayer, and a change in composition or distribution will lead to a change in shape of the bilayer. Similarly a change in shape needs to be accommodated by a change in composition and organization of the lipid core. © 2020 Elsevier Inc. All rights reserved. 2 Figure 2–2 The principle of the fluid mosaic model of biological membranes as proposed by Singer and Nicolson. In this model, globular integral membrane proteins are freely mobile within a sea of phospholipids and cholesterol. © 2020 Elsevier Inc. All rights reserved. 3 Figure 2–3 Structure of phospholipids. -
Entropy-Based Regulation of Cluster Ion Channel Density
www.nature.com/scientificreports OPEN Molecular and cellular correlates in Kv channel clustering: entropy‑based regulation of cluster ion channel density Limor Lewin1, Esraa Nsasra1, Ella Golbary1, Uzi Hadad2, Irit Orr1 & Ofer Yifrach1* Scafold protein-mediated ion channel clustering at unique membrane sites is important for electrical signaling. Yet, the mechanism(s) by which scafold protein-ion channel interactions lead to channel clustering or how cluster ion channel density is regulated is mostly not known. The voltage‑activated potassium channel (Kv) represents an excellent model to address these questions as the mechanism underlying its interaction with the post-synaptic density 95 (PSD-95) scafold protein is known to be controlled by the length of the extended ‘ball and chain’ sequence comprising the C-terminal channel region. Here, using sub-difraction high-resolution imaging microscopy, we show that Kv channel ‘chain’ length regulates Kv channel density with a ‘bell’-shaped dependence, refecting a balance between thermodynamic considerations controlling ‘chain’ recruitment by PSD-95 and steric hindrance due to the spatial proximity of multiple channel molecules. Our results thus reveal an entropy‑based mode of channel cluster density regulation that mirrors the entropy‑based regulation of the Kv channel-PSD-95 interaction. The implications of these fndings for electrical signaling are discussed. Action potential generation, propagation and the evoked synaptic potential all rely on precisely timed events associated with activation and inactivation gating transitions of voltage-dependent Na + and K + channels, clus- tered in multiple copies at unique membrane sites, such as the initial segment of an axon, nodes of Ranvier, pre-synaptic terminals or at the post-synaptic density (PSD)1–3. -
Transport of Sugars
BI84CH32-Frommer ARI 29 April 2015 12:34 Transport of Sugars Li-Qing Chen,1,∗ Lily S. Cheung,1,∗ Liang Feng,3 Widmar Tanner,2 and Wolf B. Frommer1 1Department of Plant Biology, Carnegie Institution for Science, Stanford, California 94305; email: [email protected] 2Zellbiologie und Pflanzenbiochemie, Universitat¨ Regensburg, 93040 Regensburg, Germany 3Department of Molecular and Cellular Physiology, Stanford University School of Medicine, Stanford, California 94305 Annu. Rev. Biochem. 2015. 84:865–94 Keywords First published online as a Review in Advance on glucose, sucrose, carrier, GLUT, SGLT, SWEET March 5, 2015 The Annual Review of Biochemistry is online at Abstract biochem.annualreviews.org Soluble sugars serve five main purposes in multicellular organisms: as sources This article’s doi: of carbon skeletons, osmolytes, signals, and transient energy storage and as 10.1146/annurev-biochem-060614-033904 transport molecules. Most sugars are derived from photosynthetic organ- Copyright c 2015 by Annual Reviews. isms, particularly plants. In multicellular organisms, some cells specialize All rights reserved in providing sugars to other cells (e.g., intestinal and liver cells in animals, ∗ These authors contributed equally to this review. photosynthetic cells in plants), whereas others depend completely on an ex- Annu. Rev. Biochem. 2015.84:865-894. Downloaded from www.annualreviews.org ternal supply (e.g., brain cells, roots and seeds). This cellular exchange of Access provided by b-on: Universidade de Lisboa (UL) on 09/05/16. For personal use only. sugars requires transport proteins to mediate uptake or release from cells or subcellular compartments. Thus, not surprisingly, sugar transport is criti- cal for plants, animals, and humans. -
Distribution of Glucose Transporters in Renal Diseases Leszek Szablewski
Szablewski Journal of Biomedical Science (2017) 24:64 DOI 10.1186/s12929-017-0371-7 REVIEW Open Access Distribution of glucose transporters in renal diseases Leszek Szablewski Abstract Kidneys play an important role in glucose homeostasis. Renal gluconeogenesis prevents hypoglycemia by releasing glucose into the blood stream. Glucose homeostasis is also due, in part, to reabsorption and excretion of hexose in the kidney. Lipid bilayer of plasma membrane is impermeable for glucose, which is hydrophilic and soluble in water. Therefore, transport of glucose across the plasma membrane depends on carrier proteins expressed in the plasma membrane. In humans, there are three families of glucose transporters: GLUT proteins, sodium-dependent glucose transporters (SGLTs) and SWEET. In kidney, only GLUTs and SGLTs protein are expressed. Mutations within genes that code these proteins lead to different renal disorders and diseases. However, diseases, not only renal, such as diabetes, may damage expression and function of renal glucose transporters. Keywords: Kidney, GLUT proteins, SGLT proteins, Diabetes, Familial renal glucosuria, Fanconi-Bickel syndrome, Renal cancers Background Because glucose is hydrophilic and soluble in water, lipid Maintenance of glucose homeostasis prevents pathological bilayer of plasma membrane is impermeable for it. There- consequences due to prolonged hyperglycemia or fore, transport of glucose into cells depends on carrier pro- hypoglycemia. Hyperglycemia leads to a high risk of vascu- teins that are present in the plasma membrane. In humans, lar complications, nephropathy, neuropathy and retinop- there are three families of glucose transporters: GLUT pro- athy. Hypoglycemia may damage the central nervous teins, encoded by SLC2 genes; sodium-dependent glucose system and lead to a higher risk of death.